LumbaCurve International founded in Accrington, have announced that clinical trials of their innovative back pain relief device have now been completed and the results confirm that LumbaCurve can significantly reduce lower back pain.
An abstract of the independent clinical evaluation, carried out by the University of Central Lancashire Movement Analysis Laboratory, was presented at the Society for Back Pain Research Annual Conference in Dublin, which concluded that LumbaCurve was significantly more effective compared with standard treatment guidelines currently advocated by the NHS.
The report’s conclusion stated that ‘Initial findings reported that through a four week intervention programme, significant improvements in patient reported back pain levels are demonstrated following standardised care plus LumbaCurve™ intervention’.
LumbaCurve director David Pegg commented, “Needless to say we are delighted with these findings, and as a direct result LumbaCurve has already been taken on by a major European medical distributor, and are now in talks with a potential U.S. partner.
The abstract is to be published in the Bone and Joint Journal and a Journal paper submission to the European Spine Journal is pending.
For further information about the LumaCurve visit: www.lumbacurve.com
For more information please contact Abigail Peake on 01254 356473 or [email protected]